|
業務類別
|
-- |
|
業務概覽
|
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of inventive products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategies. |
| 公司地址
| Wagistrasse 25, Schlieren, Zurich, CHE, 8952 |
| 電話號碼
| +41 447334747 |
| 傳真號碼
| +41 447334740 |
| 公司網頁
| https://www.kurosbio.com |
| 員工數量
| 122 |
| Dr. Joost de Bruijn |
Independent Director |
13/03/2025 |
| Mr. Oliver Walker |
Independent Director |
13/03/2025 |
| Mr. Albert Arp |
Independent Director |
13/03/2025 |
| Mr. Chris Fair |
Independent Director |
13/03/2025 |
| Professor Clemens van Blitterswijk |
Chairman of the Board |
13/03/2025 |
|
|
|
|
